CSM Advisors’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Buy
433,645
+71,364
+20% +$1.62M 0.23% 104
2026
Q1
$7.75M Buy
362,281
+32,129
+10% +$669K 0.19% 124
2025
Q4
$7.06M Buy
330,152
+16,477
+5% +$338K 0.19% 114
2025
Q3
$5.25M Buy
313,675
+110,877
+55% +$1.66M 0.15% 162
2025
Q2
$2.91M Buy
+202,798
New +$2.78M 0.08% 256

Other funds holding MD

CSM Advisors's MD Position: Q2 2026 in Review

CSM Advisors increased its Pediatrix Medical (MD) stake by 20% in Q2 2026, buying an estimated $1.62M and bringing the position to 433,645 shares worth $11M. The position accounts for 0.23% of the portfolio, ranked #104.

CSM Advisors first reported a position in MD in Q2 2025 and has held it in 5 quarters since. 305 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • CSM Advisors held 433,645 shares of Pediatrix Medical worth $11M as of Q2 2026.
  • CSM Advisors bought 71,364 Pediatrix Medical shares in Q2 2026, an estimated $1.62M.
  • Pediatrix Medical made up 0.23% of CSM Advisors's portfolio in Q2 2026, its #104 holding.
  • CSM Advisors first reported a position in Pediatrix Medical in Q2 2025 and has held it in 5 quarters since.
  • 305 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on CSM Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.